Click on the following links to read the articles:

Li & Fung Plunges 5.3% Amid US$500M Share Placement (3-28-2012)

Goldman Sachs Cuts Li & Fung Target Price to HK$13.20 (8-17-2011)

Li & Fung Bought Fishman & Tobin And Its 1H Net Down 15% (8-11-2011)

Li & Fung Hits 52-Week Low Amid Jobs Cuts (7-29-2011)

Citigroup and Goldman Sachs Cut Li & Fung’s Target Prices (7-26-2011)

Goldman Sachs Raises Country Garden’s Target But Downgrades Li & Fung (7-25-2011)

Li & Fung Sells Properties and Medical Business (7-4-2011)

Daiwa Slashes Li & Fung To Underperform, Target HK$14.30 (6-27-2011)

Brokers Revise Li & Fung’s Target Prices (6-23-2011)

Li & Fung Makes Five Acquisitions (6-22-2011)

Li & Fung’s Accounting Treatment In Question (5-27-2011)

UBS Slashes Li & Fung Target To HK$9.00 from HK$16.50 (5-26-2011)

Li & Fung Rises 2.2% On First Trading Day Of Share Split (5-19-2011)

CLSA Keeps Li & Fung Underperform; Target HK$40 (4-15-2011)

Li & Fung Announces 1-Into-2 Share Split Effective May 19 (4-12-2011)

Li & Fung Plunges Amid Earnings Miss; Brokers Revise Target Prices (3-25-2011)

UBS Keeps Sell Rating For Li & Fung Due To Margin Squeeze (2-8-2011)

Daiwa Lifts Li & Fung’s 6-month Target Price to HK$58.47 (2-4-2011)

Goldman Sachs Keeps Li & Fung at Buy and Raises Target to HK$54 (12-4-2010)

Li & Fung Becomes Li Ning’s Sourcing Agent, Daiwa Keeps Buy Rating (11-4-2010)

Goldman Sachs Keeps Li & Fung (Hong Kong Stock Code 0494) on Conviction Buy List (10-22-2010)

Daiwa Keeps Li & Fung At Buy. Target HK$50 (9-15-2010)

UBS Keeps Sell Call on Li & Fung (9-9-2010)